Balanced news tone
News Sentiment
SNT sentiment intelligence
Syntara Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
12 relevant articles
News tone and price action are not far from neutral.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, -4.2% over four weeks, trend inactive, and below fair value.
Why Is Syntara (ASX:SNT) Drawing Fresh Health Microcap Attention?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
95/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
-4.2% over four weeks
Fair value
-40.6%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
10
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine Media
Direct company coverage
Why Is Syntara (ASX:SNT) Drawing Fresh Health Microcap Attention?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 07:22
- Source
- Kalkine Media
Moomoo
Direct company coverage
Syntara Ltd (SNT) Stock Forum and Discussion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 02:35
- Source
- Moomoo
Kalkine
Direct company coverage
Syntara (ASX:SNT) Shares Gain Attention After Neuroinflammation Study Update
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Kalkine
Kalkine Media
Direct company coverage
Syntara (ASX:SNT): Why Is the Biotech Company Expanding Its Listed Shares?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Kalkine Media
Sharecafe
Direct company coverage
Syntara Secures A$10 Million Capital Injection to Advance Clinical Programs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- Sharecafe
simplywall.st
Direct company coverage
Is Syntara (ASX:SNT) In A Good Position To Deliver On Growth Plans?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Nov 2025 08:00
- Source
- simplywall.st
BioWorld News
Direct company coverage
Syntara’s stock plunges 52% following FDA request for added trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Aug 2025 07:00
- Source
- BioWorld News
TipRanks
Direct company coverage
Syntara Limited Schedules Investor Webinar Amidst Quarterly Update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jul 2025 07:00
- Source
- TipRanks
intelligentinvestor.com.au
Direct company coverage
Syntara Limited (ASX: SNT) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2023 08:45
- Source
- intelligentinvestor.com.au
TradingView
Direct company coverage
SNT Stock Price and Chart — ASX:SNT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Dec 2023 15:35
- Source
- TradingView
intelligentinvestor.com.au
Direct company coverage
Syntara Limited (ASX:SNT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Dec 2023 13:57
- Source
- intelligentinvestor.com.au
BiotechDispatch
Direct company coverage
A name change and significant sale as Pharmaxis becomes Syntara
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Oct 2023 07:00
- Source
- BiotechDispatch